1Swanson DR, Barclay BL, Wong PS, et al. nifedipine gastrointestinal therapeutic system[ J ]. Am J Med, 1987,21 ; 83 (6B) : 3.
2Grundy JS, Foster RT. The nifedipine gastrointestinal therapeutic system (GITS), Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties [ J ]. Clin Pharmacokinet, 1996,30(1) :28.
3Zanchetti A. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring[ J ]. J Hypertens Suppl,1994,12(5) :S23.
4Zanchetti A. Trough peak ratio the blood pressure response to dihydropyridine calcium antagonists[J]. J Hypertens Supppl, 1994,12(8) :S97.
5Krakoff LR. Effectiveness of nifedipine gastrointestinal therapeutic system for treatment of hypertension: results of the MATH Trial[ J ]. J Cardiovasc Pharmacol, 1993,21 Suppl 2 : S14.
6Toal CB, Mahon WA, Barnes C, et al. nifedipine gastrointestinal therapeutic system (GITS) for hypertensive patients in a primary care setting: results of the extended release adalat canadian trial(EXACT) [J]. Clin Ther, 1997,19(5) :924.
7Brown MJ, Castaigne A, de Leeuw PW, et al. Study population and treatment titration in the international nifedipine GITS study: intervention as a goal in hypertension treatment (INSIGHT)[J].J Hypertension ,1998,16(12 Pt 2):2113.
8Wurdeman RL, Mooss AN, Mohiuddin SM, et al. Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC [ J ]. Pharmacotherapy, 1999,19 ( 1 ) :94.
9Hilleman DE, Mohiuddin SM, Lucas BD Jr, et al. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension[J]. Clin Ther, 1993,15(6) : 1002.
10Jueng C, Halperin AN, Hashimoto F, et al. nifedipine GITS and hydrochlorothiazide in essential hypertension [ J ]. J Clin Hypertension. 1987.3(4) :695.
